MetLife Investment Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $30.2M | Sell |
292,024
-4,917
| -2% | -$439K | 0.14% | 96 |
|
|
2026
Q1 | $21.3M | Sell |
296,941
-7,092
| -2% | -$546K | 0.11% | 153 |
|
|
2025
Q4 | $24.1M | Sell |
304,033
-10,395
| -3% | -$819K | 0.12% | 124 |
|
|
2025
Q3 | $23.7M | Sell |
314,428
-7,694
| -2% | -$527K | 0.11% | 134 |
|
|
2025
Q2 | $22.2M | Sell |
322,122
-5,360
| -2% | -$351K | 0.13% | 135 |
|
|
2025
Q1 | $22.2M | Sell |
327,482
-5,652
| -2% | -$338K | 0.12% | 131 |
|
|
2024
Q4 | $15M | Buy |
333,134
+5,964
| +2% | +$335K | 0.08% | 177 |
|
|
2024
Q3 | $20.6M | Sell |
327,170
-7,788
| -2% | -$454K | 0.12% | 136 |
|
|
2024
Q2 | $19.8M | Buy |
334,958
+39,861
| +14% | +$2.49M | 0.12% | 130 |
|
|
2024
Q1 | $23.5M | Sell |
295,097
-16,629
| -5% | -$1.27M | 0.16% | 106 |
|
|
2023
Q4 | $24.6M | Sell |
311,726
-5,893
| -2% | -$419K | 0.18% | 97 |
|
|
2023
Q3 | $22.2M | Sell |
317,619
-7,756
| -2% | -$550K | 0.17% | 96 |
|
|
2023
Q2 | $22.5M | Sell |
325,375
-6,019
| -2% | -$428K | 0.16% | 101 |
|
|
2023
Q1 | $24.6M | Sell |
331,394
-11,715
| -3% | -$982K | 0.18% | 94 |
|
|
2022
Q4 | $32M | Sell |
343,109
-5,337
| -2% | -$515K | 0.24% | 72 |
|
|
2022
Q3 | $33.2M | Sell |
348,446
-4,818
| -1% | -$477K | 0.28% | 58 |
|
|
2022
Q2 | $32.7M | Sell |
353,264
-3,948
| -1% | -$385K | 0.25% | 66 |
|
|
2022
Q1 | $36.2M | Buy |
357,212
+65,556
| +22% | +$6.89M | 0.23% | 74 |
|
|
2021
Q4 | $30.1M | Sell |
291,656
-6,384
| -2% | -$590K | 0.25% | 69 |
|
|
2021
Q3 | $25.3M | Sell |
298,040
-7,200
| -2% | -$603K | 0.23% | 83 |
|
|
2021
Q2 | $25.5M | Sell |
305,240
-7,254
| -2% | -$594K | 0.22% | 82 |
|
|
2021
Q1 | $23.5M | Sell |
312,494
-5,383
| -2% | -$392K | 0.22% | 81 |
|
|
2020
Q4 | $21.7M | Sell |
317,877
-13,936
| -4% | -$906K | 0.21% | 83 |
|
|
2020
Q3 | $19.4M | Sell |
331,813
-10,040
| -3% | -$625K | 0.21% | 83 |
|
|
2020
Q2 | $22.2M | Buy |
341,853
+6,513
| +2% | +$410K | 0.25% | 73 |
|
|
2020
Q1 | $19.9M | Sell |
335,340
-10,260
| -3% | -$685K | 0.27% | 71 |
|
|
2019
Q4 | $25.7M | Sell |
345,600
-8,312
| -2% | -$584K | 0.27% | 72 |
|
|
2019
Q3 | $22.3M | Sell |
353,912
-4,168
| -1% | -$247K | 0.25% | 73 |
|
|
2019
Q2 | $19.5M | Sell |
358,080
-10,613
| -3% | -$572K | 0.21% | 85 |
|
|
2019
Q1 | $19.9M | Sell |
368,693
-1,126
| -0.3% | -$69.5K | 0.22% | 86 |
|
|
2018
Q4 | $24.2M | Buy |
369,819
+73,661
| +25% | +$5.5M | 0.29% | 65 |
|
|
2018
Q3 | $23.3M | Sell |
296,158
-3,119
| -1% | -$223K | 0.24% | 77 |
|
|
2018
Q2 | $19.3M | Sell |
299,277
-6,035
| -2% | -$398K | 0.23% | 71 |
|
|
2018
Q1 | $19M | Sell |
305,312
-8,116
| -3% | -$582K | 0.22% | 80 |
|
|
2017
Q4 | $22.7M | Buy |
+313,428
| New | +$22.8M | 0.26% | 69 |
|
Other funds holding CVS
MetLife Investment Management's CVS Position: Q2 2026 in Review
MetLife Investment Management reduced its CVS Health (CVS) stake by 1.7% in Q2 2026, selling an estimated $439K and leaving 292,024 shares worth $30.2M. The position accounts for 0.14% of the portfolio, ranked #96.
MetLife Investment Management first reported a position in CVS in Q4 2017 and has held it in 35 quarters since. The position peaked at $36.2M in Q1 2022. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- MetLife Investment Management held 292,024 shares of CVS Health worth $30.2M as of Q2 2026.
- MetLife Investment Management sold 4,917 CVS Health shares in Q2 2026, an estimated $439K.
- CVS Health made up 0.14% of MetLife Investment Management's portfolio in Q2 2026, its #96 holding.
- MetLife Investment Management first reported a position in CVS Health in Q4 2017 and has held it in 35 quarters since.
- MetLife Investment Management's CVS Health position peaked at $36.2M in Q1 2022.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.